Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DC-Signal

Financiado

Cerrado

Signaling Mechanisms Intersecting Histamine Receptors and Pattern Recognition Re...

Signaling Mechanisms Intersecting Histamine Receptors and Pattern Recognition Receptor Activation in Dendritic Cells The immune response is a tightly regulated process which normally results in protection from infection and tolerance of innocuous environmental antigens. However, in allergy and asthma, the activated immune response results in a... ver más

31/05/2013

PMOD WRC

178K€

Presupuesto del proyecto: 178K€

Líder del proyecto

SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHG... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-05-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

PMOD WRC

0.00€ | Lider

Proyectos interesantes

SAF2012-35670

Medical Technol...

Immunology

333K€ Cerrado

A20 IN ALLERGY

Medical Technol...

Immunology

219K€ Cerrado

DC IN ASTHMA

Medical Technol...

Immunology

170K€ Cerrado

TH2MEMORY

Medical Technol...

Immunology

227K€ Cerrado

BES-2013-065738

Medical Technol...

Immunology

84K€ Cerrado

PID2020-114147RB-I00

Medical Technol...

Immunology

121K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHG... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 178K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The immune response is a tightly regulated process which normally results in protection from infection and tolerance of innocuous environmental antigens. However, in allergy and asthma, the activated immune response results in a chronic pro-inflammatory state characterized by T cell Th2 polarization to normally well-tolerated antigens resulting in tissue inflammation and tissue remodeling. Dendritic cells (DCs) are essential for inducing activation and differentiation of effector CD4+ and CD8+ T cells in response to antigens, and it is well established that these cells play a pivotal role in the initiation and maintenance phase of inflammatory responses. However, the molecular basis for aberrant DC activation within inflamed tissues is poorly defined. The hypothesis to be tested in this proposal is that pattern recognition receptor (PRR) activation in the context of histamine receptor (HR) stimulation skews the DC activation program resulting in aberrant T cell polarization. Human-derived DCs and T cells from humans will be utilized in order to ensure the results obtained are relevant in vivo. This project is a significant leap forward as it combines multiple, clinically relevant, triggers of DC activation in a co-ordinated research program, which will ultimately result in the identification of new therapeutic targets for allergy and asthma patients. The original feature of this proposal relates to the elucidation of the key molecular checkpoints intersecting HR and PRR pathways, in myeloid and plasmacytoid DCs from allergy and asthmatic patients. SIAF is well placed to perform these studies as SIAF members have well-established track records in elucidating novel immunological mechanisms in allergy and asthma. The public health implications of this proposal are immense as development of novel DC modifying compounds allows clinicians to target a range of inflammatory diseases such as asthma, allergy, autoimmune disorders and inflammatory bowel disease (IBD).

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores